House Postpones Vote on Bill to Federally Legalize Marijuana Until After Election

Kyle Jaeger, writing for Marijuana Moment:

A bill to federally legalize marijuana will no longer receive a previously announced vote in the House of Representatives next week.

In an at least temporary blow to reform advocates, the legislation was not included in a weekly floor schedule posted by the office of Majority Leader Steny Hoyer (D-MD) on Thursday, though he made a commitment that the body would bring up the bill sometime “later this autumn,” presumably after the November elections. This comes two weeks after Hoyer initially said a vote was being planned for the week of September 21. […]

It appears that the decision was influenced by certain moderate Democrats who’ve expressed concern that voting on a cannabis reform bill while another round of coronavirus relief legislation is still unresolved would be bad optics for their reelection campaigns.

Turns out last month’s news about the House voting on legalizing cannabis federally was a bit short-lived. At least they’re going to do it in November. Hopefully that’ll actually happen.

---

Post Permalink

Australians Are Working on Rescheduling Psilocybin and MDMA

If you’re a regular reader here at Think Wilder then you might have noticed that I’ve slowed down a bit here on the blog over the past couple weeks, and that’s because I’ve had a lot going on in my personal life. Because of everything going on, I didn’t get around to publishing a link post for this story that broke earlier this month about the effort to reschedule psilocybin and MDMA in Australia to allow for therapeutic use. Psilocybin Alpha had the scoop:

On the 1st of September the nonprofit Mind Medicine Australia submitted a proposal to the Australian Therapeutic Goods Association (TGA), the regulatory body in charge of the island country’s drug scheduling. This proposal was submitted in hopes of reclassifying psilocybin and MDMA from prohibited substances to controlled medicines.

If this proposal is successful, Australia will become the first country in the world to reschedule these substances for therapeutic purposes, potentially giving thousands of people access to life-saving treatments, and setting a precedent that has the potential to influence global policy and attitudes towards psychedelics.

Mind Medicine Australia is requesting that people contact the TGA by September 28th to show their support. An interim decision on the proposal will be announced in February 2021 with a final decision occurring next April.

It would be pretty impressive if Australia ended up being the first country to legalize currently-illegal psychedelics like psilocybin and MDMA for therapeutic use. I certainly wasn’t expecting this—were you?

---

Post Permalink

This Week in Psychedelics - 9.11.20

Cannabis

• Medical Marijuana Measure Removed From Nebraska’s November Ballot By State Supreme Court (Marijuana Moment)

• Marijuana Is Making Its Mark on Ballots in Red States (The Daily Beast)

• Pakistan Legalizes Industrial and Medical Cannabis Aiming to Expand Global Market (MERRY JANE)

• Maine Finally Approves First Marijuana Business Licenses Weeks Before Legal Sales Launch (Marijuana Moment)

• Give cannabis to elderly people with chronic pain, doctors say (The Telegraph)

• Virginia: Marijuana-Related Bills Advance During Special Legislative Session (NORML)

• USDA Reopens Public Comment Period On Hemp Rules Following Intense Industry Pushback (Marijuana Moment)

• Key Congressional Committee Advances Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products (NORML)

• Twitter Partners With Feds On Campaign Flagging ‘Marijuana’ Searches While Giving ‘Alcohol’ A Pass (Marijuana Moment)

• Hong Kong Just Opened Its First CBD Café Despite Country's Notoriously Harsh Weed Laws (MERRY JANE)

• Greenstop launches its cannabis vending machine in California dispensaries (TechCrunch)

• Global Drug Body Recommends 20 Ways to Improve the Cannabis Industry (VICE)

• Marijuana Possession Arrests Plummet In Texas After Hemp Legalization, New State Data Shows (Marijuana Moment)

• This is how cannabis effectively eases inflammation (Chicago Tribune)

• I used to be on the police drug squad. Here's why I'm voting against legalising cannabis (Stuff.co.nz)

LSD

• LSD Tolerance Could Develop Faster than You Expect (DoubleBlind)

• Acid Tab Feeling Lot Of Pressure To Present Tech CEO With Game-Changing Ideas For Disrupting Telecom Industry (The Onion)

Magic Mushrooms

• Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin (Psilocybin Alpha)

• Bett Williams Walks Between Worlds (Lucid News)

MDMA

• MDMA-Assisted Psychotherapy for PTSD Trials Progressing Through Phase 3 (Psychiatry and Behavioral Health Learning Network)

Nitrous Oxide

• One in four drug users at festivals now get high on laughing gas - TD (Independent.ie)

Ketamine

• Esketamine spray for treating depression 'not cost-effective' (BBC)

• Colorado Society of Anesthesiologists ask CDPHE to suspend 'excited delirium' ketamine waiver (9news.com)

Miscellaneous

• Will Australia be the First Country to Reap the Benefits of Psychedelic Medicines? Rescheduling Proposal Submitted to TGA (Psilocybin Alpha)

• Depression and suicidal ideation reduced after psychedelic usage (Big Think)

• Psychedelic experiences share many features with those described by mystics and religious practitioners (PsyPost)

• Biden Pledges To Force People Who Use Drugs To Enroll In Mandatory Treatment Programs (Marijuana Moment)

• Coronavirus Conspiracy Theories in Psychedelia (Psymposia)

• Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE (Psilocybin Alpha)

• AWAKN Life Sciences Launches Clinical Research Division with Prof. David Nutt & Dr. Ben Sessa Identifying Suitable Studies Across Europe & North America (Yahoo! Finance)

• How Mescaline Helped Me to Better Understand Schopenhauer’s Philosophy (Psychedelic Frontier)

• Quipazine: A Long-Standing Enigma in Psychedelic Research (Psychedelic Science Review)

• Scientists Use Psychedelics to Discover an Anti-Inflammatory Pharmacophore (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.4.20

Cannabis

• Drone Drops Hundreds Of Free Bags Of Marijuana In Israel (Marijuana Moment)

• Virginia Senate Approves Two Marijuana Bills As Lawmakers Pursue Broader Legalization (Marijuana Moment)

• Sheriff Files Lawsuit To Keep Medical Marijuana Off Nebraska’s Ballot (Marijuana Moment)

• Malta is officially out of weed (The GrowthOp)

• Vermont Marijuana Sales Legalization Bill Inches Closer To Final Form After Conference Meeting (Marijuana Moment)

• Are rosin vape carts going to take over the market? You better hope so. (Leafly)

• Mississippi Medical Marijuana Initiative Has ‘Strong Chance Of Passage,’ Poll Shows (Marijuana Moment)

• USC researchers think THC in marijuana could treat deadly COVID complication (Bakersfield.com)

• How Legal Weed Destroyed a Counterculture Icon (Politico)

• USDA Approves Hemp Plans For Maine, Missouri And Another Indian Tribe (Marijuana Moment)

• Study: Over Three in Four Cannabis Consumers Prefer Flower Over Concentrates (NORML)

• California Must Turn Over Marijuana Documents To DEA, Federal Court Rules (Marijuana Moment)

• Cannabis extract may protect honey bees from pesticides (StratCann)

• State Of California Officially Promotes Marijuana Industry With New Campaign (Marijuana Moment)

• Marijuana Use Growing in Popularity Among Seniors (NORML)

• Marijuana Legalization Group Helps Craft New Impaired Driving Prevention Bill In Congress (Marijuana Moment)

• Medical cannabis failing Delaware patients (Cape Gazette)

Magic Mushrooms

• Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder (Psilocybin Alpha)

• Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds (Psilocybin Alpha)

• Red Light Holland Announces Arrangement to Launch Sale of Psychedelic Truffle Microdosing Packs in the Netherlands (Psilocybin Alpha)

• Cancer patients say psilocybin can be both therapy and “a beautiful experience” (Inverse)

MDMA

• Regulator weighs push to legalise MDMA for mental health treatment (Brisbane Times)

DMT

• How to Integrate a Difficult-to-Remember DMT Experience (Maps of the Mind)

• Machine Elves and a Journey Into The DMT Spirit World (DoubleBlind)

Ayahuasca

• 'A Hail Mary': Psychedelic Therapy Draws Veterans to Jungle Retreats (The New York Times)

• Miley Cyrus went vegan after ‘puking up seals’ while on hallucinogenic drug (Metro)

Peyote

• Peyote Decriminalization Opposed by Groups Seeking to Protect the Plant from Poaching (Lucid News)

Iboga

• Healing the Soul with Spray Paint and Iboga with Chor Boogie (Chacruna)

Ketamine

• Colorado on Ketamine (Reality Sandwich)

PCP

• What to Know About Daniel Prude’s Death (The New York Times)

DXM

• Dextromethorphan (DXM) Guide: Effects, Uses, Legality, and Safety (Reality Sandwich)

Miscellaneous

• Compass Pathways Files for U.S. IPO, to list on Nasdaq (Psilocybin Alpha)

• Scientists induce psychedelic-like experiences from a placebo alone (PsyPost)

• Three-In-Five DC Voters Support Psychedelics Decriminalization Initiative, New Poll Finds (Marijuana Moment)

• Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000 (Psilocybin Alpha)

• Why one in five young people have microdosed through lockdown (Dazed)

• New Wave Holdings Corp Appoints Dr. Wade Davis to Psychedelic Research Advisory Board (PR Newswire)

• Dr. Matthew Johnson Joins AWAKN Life Sciences (Psilocybin Alpha)

• Oregon Could become the First State to Decriminalize Drugs in November (The Appeal)

• Focus on the family: How the War on Drugs destroyed America’s foster care system (Leafly)

• Lamotrigine and Psychedelics (Spirit Pharmacist)

• The Mechanisms of Change in Psychedelic Assisted Psychotherapy (Psychedelic Science Review)

• The Neuroscience of Psychedelic Visuals (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Revive Therapeutics Will Study Psilocybin for Methamphetamine Use Disorder

Psilocybin Alpha:

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company has entered into a Clinical Trial Agreement (CTA), dated August 28, 2020, with the Board of Regents of the University of Wisconsin System (UWS) to conduct a clinical study entitled, “Phase I Study of the Safety and Feasibility of Psilocybin in Adults with Methamphetamine Use Disorder.” Under the terms of the CTA, the Company has an exclusive option to obtain an exclusive, worldwide, royalty-bearing commercialization license to all rights, title and interest that UWS may have or obtain in any invention that results from the clinical study.

Another potential application for psilocybin and/or psychedelics as a whole. It will be interesting to see if methamphetamine use disorder can be successfully treated with psychedelics, and lord knows the people suffering from it could really use the help. I’m hoping that we see some good results coming out of this study.

---

Post Permalink